Longer duration insulin delivery

We are developing a novel drug diffusion technology to increase the wear time and performance of a cannula to support consistent long term insulin pump use for people with type 1 diabetes.

WINNER

of the Viewers Choice Award at the Enterprise Ireland BIG IDEAS 2022

INFUSION SETS NEED TO BE FREQUENTLY CHANGED

UNTIL NOW

UNMET NEED

For people with type 1 diabetes, getting life saving insulin into their body is a lot of work. The development of insulin pump technologies has rapidly evolved over the last 50 years, however, the most important component of this system; infusion sets, have not. Infusion sets have a lifespan of 2 or 3 days and frequently fail within hours of insertion. The short lifespan and high failure rates cause more interruptions to insulin therapy, which are shown to negatively impact blood-glucose control.

Failed cannulas and the insulin discarded within them are also a waste that leads to excessive environmental impact and excessive healthcare spending.

18M

People living with type 1 diabetes (T1D) worldwide

10%

Use Insulin pumps. Low adoption due to unreliability of infusion sets

40%

of users change their infusion set early due to kinking or blocking

30%

of people with T1D would use insulin pumps if infusion sets were more reliable

MISSION

Fada Medical's mission is to optimize chronic drug therapy, making life easier for the people who need it. Starting with insulin delivery for those with type 1 diabetes, Fada Medical are developing diffusion technologies to prevent and negate the causes of early infusion set failure and cannula occlusion that make insulin therapy more difficult.